What happened
LigaChem Biosciences disclosed convertible bonds to raise US$110M, about 5.5% of its market value.
For context, this raise equals about 5.5% of the company's market value, which is the rough scale of potential new-share dilution.
| Instrument | Convertible bonds |
|---|---|
| Raise amount | US$110M |
| vs. market value | 5.5% |
| Filed | 2026-06-26, Material event report (convertible bonds) |
| Source | DART rcept 20260626000004 → open original filing |
Source: DART. Information only, not investment advice.